Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $1.04 Million - $1.25 Million
92,700 Added 177.25%
145,000 $1.73 Million
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $472,703 - $584,815
-53,900 Reduced 50.75%
52,300 $566,000
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $263,725 - $312,125
-27,500 Reduced 20.57%
106,200 $1.05 Million
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $537,592 - $613,284
59,600 Added 80.43%
133,700 $1.33 Million
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $681,720 - $908,466
74,100 New
74,100 $712,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $248,153 - $338,540
-18,260 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $261,118 - $342,192
18,260 New
18,260 $342,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.